Andrew Pointer and other shooting victims of Joseph Wesbecker hold hands as the verdict is read on Dec. 12, 1994, in their suit against Prozac maker Eli Lilly and Co. Pointer died in April
LOUISVILLE, Ky. – The drugmaker that produces Prozac, the antidepressant that Joseph Wesbecker’s victims blamed for his deadly shooting rampage 30 years ago at Standard Gravure, secretly paid the victims $20 million to help ensure a verdict exonerating the drug company.
Indianapolis-based Eli Lilly vigorously shielded the payment for more than two decades, defying a Louisville judge who fought to reveal it because he said it swayed the jury's verdict.
Wesbecker began taking Prozac about a month before his murderous spree that killed eight and wounded 12 in the print shop attached to the Courier Journal. All but one of the victims sued Eli Lilly, the company that manufactured the popular but controversial drug.
'We need change': El Paso mass shooting survivors file lawsuit against Walmart
On Sept. 14, 1989, Wesbecker, a pressman who had been placed on long-term disability leave for severe mental illness, entered Standard Gravure around 8:30 a.m., carrying a bag full of weapons, including a semiautomatic rifle.
Over the next 30 minutes, Wesbecker walked through the building, firing more than 40 rounds at those he encountered before shooting himself in the head with a handgun. It is the worst mass shooting in Kentucky's history.
In 1994, a fiercely litigated, 11-week trial took place in Louisville in which Wesbecker's victims and their families said the Prozac he took helped incite his murderous rampage.
On the eve of the jury's verdict, which absolved Lilly of liability, the company made the secret payment without telling the judge overseeing the case.
In exchange for the payment, the plaintiffs – eight estates and 11 survivors – agreed to withhold damaging evidence about the arthritis drug Oraflex that Lilly withdrew from the market. Lilly pleaded guilty to 25 criminal misdemeanor counts for failing to report adverse reactions that patients suffered from the drug, and the drug company feared that the Prozac jury would be more inclined to rule against the drugmaker if it learned of it.
The plaintiffs agreed that if the jury found Lilly liable, they would not seek damages, nor would they appeal the verdict if they lost.
America's first mass shooting: 70 years ago, a WWII veteran killed 13 of his neighbors.
Jefferson Circuit Judge John Potter forced the disclosure of a secret deal between Prozac maker Eli Lilly and company and the plaintiffs
The Courier Journal
Jefferson Circuit Judge John Potter exposed the outlines of the deal decades ago, suspecting that money may have changed hands before the verdict. He fought the company for years to disclose the deal’s terms.
Lilly closely guarded the amount of the payment, and it remained a secret in Louisville.
Two of the victims recently told the Courier Journal that the payment totaled $20 million, worth about $41 million in today’s dollars, which the plaintiffs divided among themselves after paying their attorneys. The two victims told the Courier Journal they felt compelled to accept the money because they suffered egregious injuries that kept them from working again and they needed it to survive.
They asked not to be identified because the settlement required them to keep the amount secret, and they said they feared repercussions for revealing it.
The co-lead attorney for the plaintiffs, Illinois lawyer Nancy Zettler, told the Courier Journal she was not involved in the agreement but heard the same figure cited by the two plaintiffs.
'Clearly a game.': Opioid lawsuit settlements arranged to give drug companies a tax break, experts sayThe Indianapolis Star reported the $20 million amount in 2000 and said the company paid an additional $5 million to cover workers' compensation claims.
Under the deal, the plaintiffs could have received $15 million more if Prozac had been found 51%-100% liable for Wesbecker's conduct.
Attorney Ed Stopher, who defended Lilly at trial, declined to comment and referred questions to the company, whose communication director, Mark Taylor, said it would not comment.
Lilly used the verdict to tout that Prozac had been proved a safe and effective antidepressant. In 1995, the company reaped a quarter of its $6.5 billion in revenue from Prozac – and faced 160 other suits nationwide over the drug.
Prozac is still prescribed across the USA and is considered safe if used as directed, although it does have some side effects, according to the College of Psychiatric and Neurologic Pharmacists.
The company and its lawyers acknowledged the agreement with plaintiffs (but not the amount of the payment), insisting it was legal and ethical.
They said it was not unusual for adversaries in civil trials to strike so-called high-low agreements, in which the plaintiffs and defense agree to minimum and maximum recoveries – regardless of the verdict – to reduce their respective risks.
Somerset lawyer Richard Hay said, "If parties use secret agreements to keep out evidence, it’s like taking a dive in a boxing match."
'Misleading marketing' leads to landmark judgment: Johnson & Johnson to pay $572 million for role in opioid crisis; company says ruling 'flawed'
Lilly publicly trashed Potter and his investigation and won an order from the Kentucky Court of Appeals blocking it.
Potter appealed, and the state Supreme Court unanimously ruled in his favor in 1996, allowing him to press Lilly for details of the deal.
"In this case, there was a serious lack of candor with the trial court, and there may have been deception, bad-faith conduct, abuse of the judicial process or perhaps even fraud," the court said. "We cannot tolerate even the possibility of such conduct."
Potter set a hearing at which he intended to require attorneys for both sides to testify under oath. Lilly accused him of conducting a vendetta, and he recused himself.
The judge who inherited the case let the matter drop, and Potter's questions were never answered.
Potter, 76, who retired in 2002 after 20 years on the bench, declined to comment for this story.
Posta un commento